Live Breaking News & Updates on Milestone Pharmaceuticals Daily
Stay updated with breaking news from Milestone pharmaceuticals daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Get Rating) – Research analysts at Oppenheimer issued their Q1 2023 earnings per share (EPS) estimates for Milestone Pharmaceuticals in a report released on Wednesday, April 12th. Oppenheimer analyst L. Gershell expects that the company will post earnings of ($0.38) per share for the quarter. Oppenheimer has a “Outperform” rating […] ....
Milestone Pharmaceuticals (NASDAQ:MIST – Get Rating) had its price objective cut by Oppenheimer from $16.00 to $13.00 in a research note issued to investors on Wednesday morning, The Fly reports. They currently have an outperform rating on the stock. Oppenheimer also issued estimates for Milestone Pharmaceuticals’ Q1 2023 earnings at ($0.38) EPS, Q2 2023 earnings […] ....
Milestone Pharmaceuticals (NASDAQ:MIST – Get Rating) had its target price reduced by Oppenheimer from $16.00 to $13.00 in a research note issued to investors on Wednesday, The Fly reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price objective would suggest a potential upside of 253.26% from the company’s current price. Separately, […] ....
Milestone Pharmaceuticals (NASDAQ:MIST – Get Rating) had its price target cut by Oppenheimer from $16.00 to $13.00 in a note issued to investors on Wednesday, The Fly reports. Oppenheimer’s price objective would suggest a potential upside of 238.54% from the company’s previous close. Separately, HC Wainwright restated a “buy” rating and issued a $25.00 price […] ....
HC Wainwright restated their buy rating on shares of Milestone Pharmaceuticals (NASDAQ:MIST – Get Rating) in a research report sent to investors on Thursday, Benzinga reports. HC Wainwright currently has a $25.00 target price on the stock. HC Wainwright also issued estimates for Milestone Pharmaceuticals’ FY2026 earnings at $1.07 EPS and FY2027 earnings at $2.13 […] ....